Bioxytran, Inc.
BIXT
$0.04
$0.000.84%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.12M | -2.35M | -2.46M | -3.16M | -2.37M |
| Total Depreciation and Amortization | 11.50K | 11.50K | 8.80K | 7.80K | 7.90K |
| Total Amortization of Deferred Charges | -- | 622.80K | 647.80K | 677.80K | 677.80K |
| Total Other Non-Cash Items | 594.40K | 150.70K | 242.50K | 574.30K | 193.00K |
| Change in Net Operating Assets | 990.70K | 1.15M | 1.11M | 1.46M | 1.11M |
| Cash from Operations | -526.50K | -417.40K | -449.40K | -439.00K | -381.30K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -23.10K | -29.00K | -38.10K | -22.20K | -28.20K |
| Cash from Investing | -23.10K | -29.00K | -38.10K | -22.20K | -28.20K |
| Total Debt Issued | 323.10K | 412.80K | 477.10K | 392.60K | 325.60K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 439.00K | 13.40K | 0.00 | 63.00K | 63.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 292.20K | -- | -- | -- | -- |
| Cash from Financing | 1.05M | 426.10K | 477.10K | 455.60K | 388.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 504.80K | -20.10K | -10.30K | -5.60K | -20.90K |